Capcium Inc. – FDA Inspection, Feb 24, 2023

Record Details

This FDA Inspection record concerns Capcium Inc., with an inspection on February 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Capcium Inc.
Inspection Date: February 24, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
People: Clinton J. Lott (FDA Associated Person)
Shelby N. Turner (Investigator)

View Company Profile

ID · bf240f6f-ac19-4484-8e89-0623a1f24020

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1199601
FDA center: Human Drugs
Project area: Drug Quality Assurance

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Capcium Inc.

FDA Inspection

Capcium Inc.February 24, 2023